Aqua[1,1-bis(4-hydroxyphenyl)-1,2-diamino-2-phenylethane]sulfatoplatinum(II), a new compound for the treatment of the mammary carcinomaGUST, R.Archiv der Pharmazie (Weinheim). 1994, Vol 327, Num 1, pp 49-54, issn 0365-6233Article

Investigation of the conformational influences of the estrogenic activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)-ethylenediamines of their platinum(II) complexes. II: Synthesis and studies on the estrogenic activity of cis- and trans[bis(2,6-dichloro-4-hydroxybenzylamine)]dihaloplatinum(II)-complexesGUST, R; SCHÖNENBERGER, H.Archiv der Pharmazie (Weinheim). 1994, Vol 327, Num 12, pp 763-769, issn 0365-6233Article

Synthesis and evaluation of the anti-mammary tumor activity and of the estrogenic side effects of [1,2-bis(dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexesGUST, R; SCHÖNENBERGER, H.European journal of medicinal chemistry. 1993, Vol 28, Num 2, pp 103-115, issn 0223-5234Article

Third generation antitumor platinum(II) complexes of the [1-(fluoro/difluorophenyl)-2-phenylethylenediamine]platinum(II) typeGUST, R; SCHÖNENBERG, H.Archiv der Pharmazie (Weinheim). 1995, Vol 328, Num 7-8, pp 595-603, issn 0365-6233Article

Breast cancer-inhibiting properties of leaving group derivatives of [1,2-bis(2,6-difluoro-3-hydroxyphenyl)ethylenediamine]platinum(II)GUST, R; SCHÖNENBERGER, H.European journal of medicinal chemistry. 1993, Vol 28, Num 2, pp 117-127, issn 0223-5234Article

Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes. III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexesGUST, R; SCHÖNENBERGER, H.Archiv der Pharmazie (Weinheim). 1993, Vol 326, Num 7, pp 405-413, issn 0365-6233Article

Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administrationGUST, R; MCCARTHY, T. J; KOZLOWSKI, J et al.American journal of respiratory and critical care medicine. 1999, Vol 159, Num 2, pp 563-570, issn 1073-449XArticle

Crystal structure of (E)-[1-(2-chloro-5-methoxyphenyl)-2-(2,6-dichloro-4-methoxy)ethene], (CH₃O)(C₆H₂Cl₂)(CH)₂(C₆H₃Cl)(OCH₃)KLEMENT, U; RANGE, K.-J; GUST, R et al.Zeitschrift für Kristallographie. 1996, Vol 211, Num 11, issn 0044-2968, p. 854Article

Crystal structure of erythro-1-(2,6-dichloro-4-methoxyphenyl)-2-(2,6-difluoro-4-methoxyphenyl)-1,2-diazidoethane, (CH₃O)(C₆H₂Cl₂)(CHN₃)₂(C₆H₂F₂)(OCH₃)KLEMENT, U; RANGE, K.-J; GUST, R et al.Zeitschrift für Kristallographie. 1996, Vol 211, Num 11, issn 0044-2968, p. 852Article

[1,2-bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. III: Detailed evaluation of the antitumor activity of the enantiomeric complexes on the human NIH:OVCAR-3 ovarian cancer cell lineBERNHARDT, G; GUST, R; RANGE, K. J et al.Journal of cancer research and clinical oncology. 1992, Vol 118, Num 3, pp 209-215, issn 0171-5216Article

Stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]platinum(II) complexes. III: Evaluation of the mammary tumor inhibiting propertiesSCHERTL, S; GUST, R; MÜLLER, R et al.Archiv der Pharmazie (Weinheim). 1992, Vol 325, Num 2, pp 113-118, issn 0365-6233Article

Postoperative 12-lead ECG predicts peri-operative myocardial ischaemia associated with myocardial cell damageBÖTTIGER, B. W; MOTSCH, J; MARTIN, E et al.Anaesthesia. 2004, Vol 59, Num 11, pp 1083-1090, issn 0003-2409, 8 p.Article

30-jährige Bodybuilder mit septischem Schock und ARDS bei Abusus anabol-androgener Steroide = A 30-year-old body builder with septic shock and ARDS by abuse of anabolic steroidsHERR, A; REHMERT, G; KUNDE, K et al.Der Anaesthesist (Berlin. Print). 2002, Vol 51, Num 7, pp 557-563, issn 0003-2417, 7 p.Article

[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfatoplatinum(II) - pharmacokinetic studiesBERNHARDT, G; KOCH, M; SPRUSS, T et al.Archiv der Pharmazie (Weinheim). 1999, Vol 332, Num 6, pp 195-200, issn 0365-6233Article

Development of a parenterally administrable hydrosol preparation of the third generation platinum complex [(±)-1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II). I: Preparation and studies on the stability and antitumor activityGUST, R; BERNHARDT, G; SPRUSS, T et al.Archiv der Pharmazie (Weinheim). 1995, Vol 328, Num 9, pp 645-653, issn 0365-6233Article

[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancerSPRUSS, T; SHERTL, S; SCHNEIDER, M. R et al.Journal of cancer research and clinical oncology. 1993, Vol 119, Num 12, pp 707-716, issn 0171-5216Article

Crystal structure, solution chemistry, and antitumor activity of diastereomeric [1,2-bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexesGUST, R; SCHÖNENBERGER, H; KRITZENBERGER, J et al.Inorganic chemistry (Print). 1993, Vol 32, Num 26, pp 5939-5950, issn 0020-1669Article

Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethyledediamine](sulfato)platinum-(II) complexes with variable substituents in the 2-phenyl ring. I, Synthesis and antitumor and estrogenic propertiesGUST, R; BURGEMEISTER, T; MANNSCHRECK, A et al.Journal of medicinal chemistry (Print). 1990, Vol 33, Num 9, pp 2535-2544, issn 0022-2623Article

Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexesJENNERWEIN, M; WAPPES, B; GUST, R et al.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 4, pp 347-358, issn 0171-5216, 12 p.Article

Effect of patient-controlled analgesia on pulmonary complications after coronary artery bypass graftingGUST, R; PECHER, S; GUST, A et al.Critical care medicine. 1999, Vol 27, Num 10, pp 2218-2223, issn 0090-3493Article

Bedside troponin T testing is not useful for early out-of-hospital diagnosis of myocardial infarctionGUST, R; GUST, A; BÖTTIGER, B. W et al.Acta anaesthesiologica scandinavica. 1998, Vol 42, Num 4, pp 414-417, issn 0001-5172Article

Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin derivativeGUST, R; SCHNURR, B; KRAUSER, R et al.Journal of cancer research and clinical oncology. 1998, Vol 124, Num 11, pp 585-597, issn 0171-5216Article

Crystal structure of 1-(2-chloro-4-methoxyphenyl)-2-(2,6-dichloro-4-methoxyphenyl)ethane, (CH₃O)(C₆H₃Cl)(CH₂)₂(C₆H₂Cl₂)(OCH₃)KLEMENT, U; RANGE, K.-J; GUST, R et al.Zeitschrift für Kristallographie. 1996, Vol 211, Num 11, issn 0044-2968, p. 853Article

Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes : testing on the human ovarian cancer cell lines NIH : OVCAR 3 andf SK OV 3BERNHARDT, G; MÜLLER, R; GUST, R et al.Archiv der Pharmazie (Weinheim). 1992, Vol 325, Num 2, pp 93-99, issn 0365-6233Article

Mammary tumor inhibiting properties of the (S,S)-configurated [1,2-bis(4-hydroxypehnyl)ethylenediamine]dichloroplatinum(II) complexSPRUSS, T; GUST, R; MULLER, R et al.Archiv der Pharmazie (Weinheim). 1990, Vol 323, Num 2, pp 99-102, issn 0365-6233Article